Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 17320513646 |
| E-mail: | mike@molcoo.com |
| QQ: | 3001071511 |
| Skype: | Chat Now! |
| Address: | Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China |
|
1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability.
2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs.
3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects.
4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes.
5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.
|
|
| Product Name | MF | CAS | Details |
|---|
| 3978-11-8 | C11H12N2O4 | 3978-11-8 | Details |
| 714963-28-7 | C11H17NO4 | 714963-28-7 | Details |
| Olmesartan Medoxomil EP Impurity | C48H44N6O6 | 1020157-01-0 | Details |
| Calcium Levofolinate Impurity E | C15H16N6O4 | 944737-05-7 | Details |
| 1580491-16-2 | C32H38N8O4 | 1580491-16-2 | Details |
| 123171-59-5 | C19H28Cl2N6O6S2 | 123171-59-5 | Details |
| 216576-74-8 | C8H15NO2 | 216576-74-8 | Details |
| Hydrochlorothiazide EP Impurity D | C7H7Cl2N3O4S2 | 5233-42-1 | Details |
| 108-30-5 | C4H4O3 | 108-30-5 | Details |
| 142-73-4 | C4H7NO4 | 142-73-4 | Details |
| 2227442-13-7 | C21H21F2N3O5 | 2227442-13-7 | Details |
| 1492-18-8 | C20H25CaN7O7 | 1492-18-8 | Details |
| 1239908-20-3 | C20H23BCl2N2O9 | 1239908-20-3 | Details |
| 139481-69-9 | C25H22N6O3 | 139481-69-9 | Details |
| Azilsartan impurity Q | C35H28N4O11 | 1604812-35-2 | Details |
| Benazepril Enantiomer | C24H28N2O5HCl | 215447-89-5 | Details |
| 35011-47-3 | C4H9N5O5S | 35011-47-3 | Details |
| 486460-21-3 | C6H7F3N4 | 486460-21-3 | Details |
| 139756-03-9 | C17H22N4O3 | 139756-03-9 | Details |
| 326495-23-2 | C45H91Na2O16P | 326495-23-2 | Details |
| 1217834-81-5 | C14H22O4 | 1217834-81-5 | Details |
| 139481-58-6 | C26H24N6O3 | 139481-58-6 | Details |
| 139481-59-7 | C24H20N6O3 | 139481-59-7 | Details |
| Gadobutrol Impurity | C10H22N4O2 | 170454-90-7 | Details |
| Dasatinib Impurity | C15H11Cl2N5OS | 302964-27-8 | Details |
| Tadalafil EP impurity F | C22H19N3O6 | 2747958-44-5 | Details |
| 2140-61-6 | C10H15N3O5 | 2140-61-6 | Details |
| 128779-47-5 | C20H23NO4 | 128779-47-5 | Details |
| 2238824-43-4 | C26H35Cl3N4O4 | 2238824-43-4 | Details |
| 2081883-50-1 | C14H27N3O3 | 2081883-50-1 | Details |
| 5434-20-8 | C8H7NO4 | 5434-20-8 | Details |
| posaconazole Impurity | C37H42F2N8O4 | 170985-61-2 | Details |
| Posaconazole Impurity | C37H42F2N8O4 | 171228-51-6 | Details |
| 131944-48-4 | C44H69NO12 | 131944-48-4 | Details |
| 582314-82-7 | C8H10N2O | 582314-82-7 | Details |
| 1282489-71-7 | C8H10N2O | 1282489-71-7 | Details |
| 1452128-53-8 | C18H17ClN6O3 | 1452128-53-8 | Details |
| 104301-63-5 | C8H10N4O3S | 104301-63-5 | Details |
| ent-posaconazole | C37H42F2N8O4 | 2243785-97-7 | Details |
| 1643116-22-6 | C8H11N5O | 1643116-22-6 | Details |
| 1181267-36-6 | C21H31N3O3 | 1181267-36-6 | Details |
| 1696392-11-6 | C24H21N3O4 | 1696392-11-6 | Details |
| 204255-11-8 | C16H31N2O8P | 204255-11-8 | Details |
| 42399-40-6 | C20H24N2O3S | 42399-40-6 | Details |
| 150812-33-2 | C7H3Br2ClO2 | 150812-33-2 | Details |
| 1391052-76-8 | C13H8Cl2F2N2O3 | 1391052-76-8 | Details |
| 16130-28-2 | C11H12O4 | 16130-28-2 | Details |
| 1821769-41-8 | C14H23ClN2 | 1821769-41-8 | Details |
| 1642629-94-4 | C16H21N3O6S | 1642629-94-4 | Details |
| 91526-17-9 | C6H6O5 | 91526-17-9 | Details |
| 501009-13-8 | C7H3Br2ClO2 | 501009-13-8 | Details |
| 1974279-20-3 | C26H31N7O3 | 1974279-20-3 | Details |
| 1361531-95-4 | C24H30F2O6 | 1361531-95-4 | Details |
| 356-12-7 | C26H32F2O7 | 356-12-7 | Details |
| 130826-91-4 | C17H19NO4 | 130826-91-4 | Details |
| 856838-98-7 | C10H19NO2 | 856838-98-7 | Details |
| 2204442-50-0 | C24H29N7O2 | 2204442-50-0 | Details |
| 2138169-93-2 | C41H47N5O2S2 | 2138169-93-2 | Details |
| 175481-37-5 | C13H18N2O3 | 175481-37-5 | Details |
| 154445-77-9 | C34H40N4O7S | 154445-77-9 | Details |
| 812-01-1 | CH3ClO3S | 812-01-1 | Details |
| 149809-43-8 | C21H21F2N3O4S | 149809-43-8 | Details |
| Moxifloxacin Impurity Q | C16H15F2NO4 | 1329836-33-0 | Details |
| Tenofovir Alafenamide Impurity 37 | C21H29N6O5P | 383365-04-6 | Details |
| 2211054-90-7 | C10H8Br2N4O2 | 2211054-90-7 | Details |
| 139481-44-0 | C25H21N3O3 | 139481-44-0 | Details |
| 25122-45-6 | C24H30ClFO5 | 25122-45-6 | Details |
| 21829-28-7 | C19H22N2O6 | 21829-28-7 | Details |
| 936-59-4 | C9H9ClO | 936-59-4 | Details |
| 41198-42-9 | C19H16O2 | 41198-42-9 | Details |
| 1151944-57-8 | C12H9NO3S2 | 1151944-57-8 | Details |
| 1246922-88-2 | C6H7BrN2O2 | 1246922-88-2 | Details |
| 951661-82-8 | C20H19N3O3 | 951661-82-8 | Details |
| 951661-81-7 | C22H20ClN3O4 | 951661-81-7 | Details |
| 6736-40-9 | C6H10N4O | 6736-40-9 | Details |
| 212322-56-0 | C18H22N4O3 | 212322-56-0 | Details |
| 143688-83-9 | C21H23NO4 | 143688-83-9 | Details |
| 2767571-66-2 | C26H26F2N6O2S | 2767571-66-2 | Details |
| 25383-06-6 | C3H7O3P | 25383-06-6 | Details |
| 143824-78-6 | C31H30N2O6 | 143824-78-6 | Details |
| 866044-63-5 | C26H30N2O7 | 866044-63-5 | Details |
| 68858-20-8 | C20H21NO4 | 68858-20-8 | Details |
| 200623-62-7 | C39H34N2O5 | 200623-62-7 | Details |
| 84793-07-7 | C24H27NO6 | 84793-07-7 | Details |
| 132327-80-1 | C39H34N2O5 | 132327-80-1 | Details |
| 35661-60-0 | C21H23NO4 | 35661-60-0 | Details |
| 951661-85-1 | C20H19N3O3 | 951661-85-1 | Details |
| 35661-40-6 | C24H21NO4 | 35661-40-6 | Details |
| 136285-65-9 | C14H18N2O6 | 136285-65-9 | Details |
| 71989-23-6 | C21H23NO4 | 71989-23-6 | Details |
| 71989-38-3 | C28H29NO5 | 71989-38-3 | Details |
| 29022-11-5 | C17H15NO4 | 29022-11-5 | Details |
| 1369773-39-6 | C48H56CaN2O10 | 1369773-39-6 | Details |
| Nifedipine Impurity 38 | C17H16N2O7 | 145655-13-6 | Details |
| Candesartan Impurity | C23H21N3O2 | 136285-69-3 | Details |
| 136285-67-1 | C23H19N3O4 | 136285-67-1 | Details |
| 189038-36-6 | C16H20FN3O5 | 189038-36-6 | Details |
| 556801-15-1 | C16H21N3O4 | 556801-15-1 | Details |
| 144256-26-8 | C25H39N3O8 | 144256-26-8 | Details |
| 2089301-32-4 | 2089301-32-4 | Details |
| Product Total： Product Page： | ||||
| 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 | ||||